| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |